Ramanjit Kaur

Employment

• NYU Grossman School of Medicine Research Scientist
  2023 - Present
• NYU Langone Medical Center Postdoctoral fellow
  2018 - Present

Education

• Indian Institute of Technology Roorkee Ph.D.
  2013 - 2018
• Panjab University Master of Science (M.Sc)
  2010 - 2012
• Panjab University Bachelor of Science (B.Sc)
  2007 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4)
  mBio 2023 DOI: 10.1128/mbio.01090-23
  +Save
• The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target
  Cell Death Differentiation 2021 DOI: 10.1038/s41418-021-00900-1
  +Save
• An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
  Cell Reports 2020 DOI: 10.1016/j.celrep.2020.108528
  +Save
• A HIGHLY SENSITIVE NSP1 ENZYME ASSAY AND KIT FOR DETERMINING INHIBITORS OF ALPHAVIRUS/CHIKUNGUNYA VIRUS
  2019
  +Save
• Structure–Function Relationship of Negative-Stranded Viral RNA Polymerases
  Viral Polymerases 2019 DOI: 10.1016/b978-0-12-815422-9.00002-4
  +Save
• Glycan-dependent chikungunya viral infection divulged by antiviral activity of NAG specific chi-like lectin.
  Virology 2018 DOI: 10.1016/j.virol.2018.10.009
  +Save
• Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme.
  Virus research 2018 DOI: 10.1016/j.virusres.2018.06.013
  +Save
• Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease.
  Biochimie 2018 DOI: 10.1016/j.biochi.2018.04.004
  +Save
• Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein.
  Antiviral research 2017 DOI: 10.1016/j.antiviral.2017.08.015
  +Save